Profile	GDS3514 / 209440_at
Title	Liposarcoma response to doxorubicin in vitro
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM325240	Patient no. 1: control	4928.62	94
GSM325241	Patient no. 1: treated	5518.11	94
GSM325242	Patient no. 9: control	1570.74	83
GSM325243	Patient no. 9: treated	1616.1	83
GSM325244	Patient no. 18: control	1457.46	81
GSM325245	Patient no. 18: treated	1139.41	76
GSM325246	Patient no. 12: control	1044.65	76
GSM325247	Patient no. 12: treated	1123.64	77
GSM325248	Patient no. 3: control	2574.11	88
GSM325249	Patient no. 3: treated	3242.97	90
GSM325250	Patient no. 7: control	2486.15	88
GSM325251	Patient no. 7: treated	1476.82	81
GSM325252	Patient no. 15: control	1808.65	84
GSM325253	Patient no. 15: treated	1605.51	82
GSM325254	Patient no. 4: control	2076.83	86
GSM325255	Patient no. 4: treated	1304.07	78
GSM325256	Patient no. 19: control	1271.12	79
GSM325257	Patient no. 19: treated	851.347	72
GSM325258	Patient no. 14: control	1731.56	83
GSM325259	Patient no. 14: treated	1413.9	80
GSM325260	Patient no. 13: control	1952.2	85
GSM325261	Patient no. 13: treated	1479.22	80
GSM325262	Patient no. 17: control	2672.73	89
GSM325263	Patient no. 17: treated	2194.73	86
GSM325264	Patient no. 10: control	3371.88	91
GSM325265	Patient no. 10: treated	2248.58	86
GSM325266	Patient no. 5: control	2907.47	89
GSM325267	Patient no. 5: treated	1689.98	83
GSM325268	Patient no. 11: control	3153.21	91
GSM325269	Patient no. 11: treated	3228.5	90
GSM325270	Patient no. 6: control	1427.53	80
GSM325271	Patient no. 6: treated	3595.6	91
GSM325272	Patient no. 8: control	1421.17	80
GSM325273	Patient no. 8: treated	1173.67	77
GSM325274	Patient no. 16: control	1643.95	82
GSM325275	Patient no. 16: treated	1135.92	77
GSM325276	Patient no. 2: control	2825.77	89
GSM325277	Patient no. 2: treated	4273.92	92